Neumann, Peter J.

Recommendations for Conduct, Methodological Practices, and Reporting of Cost-effectiveness Analyses: Second Panel on Cost-Effectiveness in Health and Medicine

Sanders, G. D., Neumann, P. J., Basu, A., Brock, D. W., Feeny, D., Krahn, M., Kuntz, K. M., Meltzer, D. O., Owens, D. K., Prosser, L. A., et al. (2016) · JAMA

Health Systems, Economic Evaluations, Quality of LifePharmaceutical Economics and Policy

Cited by 3,069

Updating cost-effectiveness—the curious resilience of the $50,000-per-QALY threshold

Neumann, P. J., Cohen, J. T., & Weinstein, M. C. (2014) · New England Journal of Medicine

Health Systems, Economic Evaluations, Quality of LifeEconomic and Environmental Valuation

Cited by 2,249

Economic impact of childhood and adult attention-deficit/hyperactivity disorder in the United States

Doshi, J. A., Hodgkins, P., Kahle, J., Sikirica, V., Cangelosi, M. J., Setyawan, J., Erder, M. H., & Neumann, P. J. (2012) · Journal of the American Academy of Child & Adolescent Psychiatry

Attention Deficit Hyperactivity DisorderHealth Systems, Economic Evaluations, Quality of Life

Cited by 440

Examining the Value and Quality of Health Economic Analyses: Implications of Utilizing the QHES

Ofman, J. J., Sullivan, S. D., Neumann, P. J., Chiou, C.-F., Henning, J. M., Wade, S. W., & Hay, J. W. (2003) · Journal of Managed Care Pharmacy

Health Systems, Economic Evaluations, Quality of LifeMeta-analysis and systematic reviews

Cited by 366

Dementia Diagnosis Disparities by Race and Ethnicity

Lin, P.-J., Daly, A. T., Olchanski, N., Cohen, J. T., Neumann, P. J., Faul, J. D., Fillit, H. M., & Freund, K. M. (2021) · Medical Care

Dementia and Cognitive Impairment ResearchHealth disparities and outcomes

Cited by 239

Potentially avoidable hospitalizations among Medicare beneficiaries with Alzheimer's disease and related disorders

Lin, P., Fillit, H. M., Cohen, J. T., & Neumann, P. J. (2013) · Alzheimer's & Dementia

Dementia and Cognitive Impairment ResearchPharmaceutical Practices and Patient Outcomes

Cited by 142

Medicare Expenditures of Individuals with Alzheimer's Disease and Related Dementias or Mild Cognitive Impairment Before and After Diagnosis

Lin, P., Zhong, Y., Fillit, H. M., Chen, E., & Neumann, P. J. (2016) · Journal of the American Geriatrics Society

Dementia and Cognitive Impairment ResearchHealthcare Policy and Management

Cited by 127

Lethality of Alzheimer Disease and Its Impact on Nursing Home Placement

Arrighi, H. M., Neumann, P. J., Lieberburg, I. M., & Townsend, R. J. (2010) · Alzheimer Disease & Associated Disorders

Dementia and Cognitive Impairment ResearchGeriatric Care and Nursing Homes

Cited by 126

Analytic Considerations in Applying a General Economic Evaluation Reference Case to Gene Therapy

Drummond, M. F., Neumann, P. J., Sullivan, S. D., Fricke, F.-U., Tunis, S., Dabbous, O., & Toumi, M. (2019) · Value in Health

Health Systems, Economic Evaluations, Quality of LifePharmaceutical Economics and Policy

Cited by 92

Racial and Ethnic Differences in Hospice Use and Hospitalizations at End-of-Life Among Medicare Beneficiaries With Dementia

Lin, P.-J., Zhu, Y., Olchanski, N., Cohen, J. T., Neumann, P. J., Faul, J. D., Fillit, H. M., & Freund, K. M. (2022) · JAMA Network Open

Palliative Care and End-of-Life IssuesDementia and Cognitive Impairment Research

Cited by 71

The Cost-Effectiveness of Oral Nutrition Supplementation for Malnourished Older Hospital Patients

Zhong, Y., Cohen, J. T., Goates, S., Luo, M., Nelson, J., & Neumann, P. J. (2017) · Applied Health Economics and Health Policy

Clinical Nutrition and GastroenterologyNutrition and Health in Aging

Cited by 64

Hospitalizations for ambulatory care sensitive conditions and unplanned readmissions among Medicare beneficiaries with Alzheimer's disease

Lin, P., Zhong, Y., Fillit, H. M., Cohen, J. T., & Neumann, P. J. (2017) · Alzheimer's & Dementia

Dementia and Cognitive Impairment ResearchHealthcare Policy and Management

Cited by 61

Accelerating Alzheimer's disease drug innovations from the research pipeline to patients

Goldman, D. P., Fillit, H., & Neumann, P. (2018) · Alzheimer's & Dementia

Alzheimer's disease research and treatmentsPharmaceutical Economics and Policy

Cited by 30

Life-Sustaining Treatments Among Medicare Beneficiaries with and without Dementia at the End of Life

Zhu, Y., Olchanski, N., Cohen, J. T., Freund, K. M., Faul, J. D., Fillit, H. M., Neumann, P. J., & Lin, P.-J. (2023) · Journal of Alzheimer’s Disease

Palliative Care and End-of-Life IssuesEthics and bioethics in healthcare

Cited by 16

Recommendations on Perspectives for the Reference Case

Neumann, P. J., Sanders, G. D., Basu, A., Brock, D. W., Feeny, D., Krahn, M., Kuntz, K. M., Meltzer, D. O., Owens, D. K., Prosser, L. A., et al. (2016) · Cost-Effectiveness in Health and Medicine

Health Systems, Economic Evaluations, Quality of LifeEconomic and Environmental Valuation

Cited by 12

P2‐433: 30‐Day Hospital Readmissions Among Medicare Beneficiaries With Alzheimer’s Disease and Related Dementias Prior to and Following Diagnosis

Lin, P.-J., Zhong, Y., Fillit, H. M., Chen, E., & Neumann, P. J. (2016) · Alzheimer's & Dementia

Dementia and Cognitive Impairment ResearchHealthcare Policy and Management

Cited by 2

Cost-Effectiveness of the 15 Drugs Selected for Initial Price Applicability Year 2027 by Centers for Medicare and Medicaid Services Drug Price Negotiation Program

Xie, F., Zhou, T., Ma, Y., Cohen, J. T., & Neumann, P. J. (2026) · Value in Health

Health Systems, Economic Evaluations, Quality of LifePharmaceutical Economics and Policy

Cited by 1